Yes, a lipid profile is required preoperatively for patients undergoing CABG with MVR and TV repair.
All patients undergoing CABG should receive statin therapy unless contraindicated, and an adequate dose of statin should be used to reduce LDL cholesterol to less than 100 mg/dL with at least a 30% lowering of LDL cholesterol 1. This is a Class I recommendation with Level of Evidence A, meaning you must obtain a lipid profile to guide statin dosing and monitor treatment targets.
Why the Lipid Profile is Essential
The lipid profile serves multiple critical purposes in this clinical scenario:
Baseline assessment: You need to know the starting LDL cholesterol level to calculate the required 30% reduction and determine if the patient is already at goal (<100 mg/dL, or <70 mg/dL for very high-risk patients) 1
Statin dosing guidance: The lipid profile directly informs whether you need to initiate or intensify statin therapy preoperatively. For patients not already on statins or not at LDL goal, intensive statin therapy should be initiated preoperatively (ideally no later than 1 week before surgery) 1
Prognostic information: Untreated hyperlipidemic patients have been shown to have higher risk of post-CABG events compared to treated hyperlipidemic patients and those with normal lipid concentrations 1
Timing and Implementation
Obtain the lipid profile immediately if not already available from recent testing (within the past 3 months). The evidence shows:
Preoperative statin use is associated with reduced rates of postoperative MI, death, atrial fibrillation, neurological dysfunction, renal dysfunction, and infection 1
For urgent or emergency CABG patients not taking a statin, initiate high-dose statin therapy immediately (Class IIa recommendation) 1
Postoperatively, resume statin therapy when the patient can take oral medications and continue indefinitely 1
Critical Caveat
Never discontinue existing statin or dyslipidemic therapy before or after CABG in patients without adverse reactions—this is a Class III: HARM recommendation 1. Patients in whom statins were discontinued after CABG have been shown to have higher mortality rates than those in whom statins were continued postoperatively 1.
The fact that this patient is also undergoing MVR and TV repair does not change the CABG-related lipid management requirements. The coronary disease component drives the absolute need for lipid assessment and statin therapy optimization.